Molecule
Molecule
molucle img

Chemistry at the Core

We design innovative small molecules that precisely inhibit clinically proven kinase targets to solve for the dual challenges of resistance and selectivity.

An elderly couple enjoying a peaceful day on the beach. An elderly couple enjoying a peaceful day on the beach. An elderly couple enjoying a peaceful day on the beach.
molucle img

Built for Patients

We partner with physician-scientists to identify patient needs and the limitations of existing therapies.

Driven by Purpose

We are passionate about using our expertise to address the needs of patients with cancer.

Ruth Adams

Ruth Adams

Vice President, Clinical Operations

Jason Agostinelli

Finance
Kari Andrews

Kari Andrews

Clinical
Kristin Andrews

Kristin Andrews, PhD

Chemistry
Armstrong-Ingrid

Ingrid Armstrong, MS

Clinical
Alex Balcom

Alex Balcom, MBA, CPA

Chief Financial Officer
Leah Bennis, MPA

Leah Bennis, MPA

Regulatory Affairs
Jessica Bond

Jessica Bond

Pharmaceutical Development
Jim Burgeson

Jim Burgeson, MS

Pharmaceutical Development
Kristi Byrnes

Kristi Byrnes

Quality
Matthew Campbell

Matthew Campbell

Pharmaceutical Development
Liz Candido

Liz Candido

Operations
Stephanie Ceballos

Stephanie Ceballos

Information Technology
Smruti Chaudhari

Smruti Chaudhari, PhD

Pharmaceutical Development
Sibao Chen

Sibao Chen, PhD

Pharmaceutical Development
Paula Chubet

Paula Chubet

Legal
Christopher Cooper

Christopher Cooper, PhD

Pharmaceutical Development

Leah Crabtree, CPA

Finance
Crespo-Jessica

Jess Crespo, CPA

Finance
Steve Critchley

Steve Critchley

Pharmaceutical Development
Shannon Dauksis

Shannon Dauksis, PharmD

Program Management
DeLaRosa-Rachel

Rachel DeLaRosa, RN

Clinical
Karen Ellis

Karen Ellis

Program Management
Philip Engel

Philip Engel

Information Technology
Jenn Fairbanks

Jenn Fairbanks

Clinical
Wenzhe Fan

Wenzhe Fan, PhD

Pharmaceutical Development
Scott Faulhaber

Scott Faulhaber, MBA

Clinical Supply Chain
Megan Flynn

Megan Flynn

Medical Affairs
Jesus Garza

Jesus Garza, MA

Finance
Baudouin Gerard

Baudouin Gerard, PhD

Pharmaceutical Development
Gibson Tina

Tina Gibson, MS

Quality
Nurisha Gobin

Nurisha Gobin, PharmD, MBA, RPh

Regulatory Affairs
Andrew Havens

Andrew Havens

Legal
Sophie Higgins

Sophie Higgins, MPH

Regulatory Affairs
Joshua Horan

Joshua Horan, PhD

Vice President, Chemistry
Brett Hubbard, RN

Brett Hubbard, RN

Clinical
Tina Kehrig

Tina Kehrig

Clinical
Ray Kemper

Ray Kemper, PhD, DABT

Translational Development
Gloria (Glo) Kennedy

Gloria (Glo) Kennedy, RN

Clinical
Jason Kropp

Jason Kropp

Pharmaceutical Development
Shashank Kulkarni

Shashank Kulkarni, PhD

Chemistry
Joshua Lance

Joshua Lance, JD

Legal
Benjamin Lane

Benjamin Lane, PhD

Senior Vice President, Technical Operations
Lidya Le

Lidya Le

Clinical
Jeffrey Lee

Jeffrey Lee

Information Technology
Megan Lichtenfels

Megan Lichtenfels, CPA

Finance
Jessie Lin

Jessie Lin

Vice President, Corporate Strategy & Portfolio Management
Lister-Chelcie

Chelcie Lister

Corporate Development
Mei Liu, PhD

Mei Liu, PhD

Clinical
Allison Magnan

Allison Magnan

Quality
Joseph Magrino

Joseph Magrino, PhD

Biology
Ren Main

Ren Main

Finance
Morgan Maiola

Morgan Maiola, MS

Quality

Sowjanya Mangipudi, MS

Clinical
Steve Margossian, MD, PhD

Steve Margossian, MD, PhD

Clinical
Christian Martin

Christian Martin

Translational Development
Nathan McConarty

Nathan McConarty, JD

Legal
Scot Mente

Scot Mente, PhD

Chemistry
Matthew Metivier

Matthew Metivier, MBA

Senior Vice President,
Human Resources
Deb Miller

Deb Miller, MMSc, PhD, JD

Chief Legal Officer
Tuan Minh Nguyen

Tuan Minh Nguyen, PhD

Biology

Kevin Newkirk

Program Management

Victoria Nigro, MBA, MS

Clinical Supply Chain
Darlene Noci

Darlene Noci, ALM

Chief Development Officer

Matthew O’Connor

Clinical
Lorina Ouimette

Lorina Ouimette

Clinical
Marco Palencia

Marco Palencia

Clinical
Pascucci Natalia

Natalia Pascucci, MBA

Clinical

Meghavi Patel

Pharmaceutical Development
Henry Pelish

Henry Pelish, PhD

Chief Scientific Officer

James Porter, PhD

Chief Executive Officer
Bob Prytko

Bob Prytko, MSc

Pharmaceutical Development
Gosia Riley

Gosia Riley, MA

Clinical
Jose Rios Lizarraga

José Rios Lizarraga, PhD

Pharmaceutical Development
Amy Rochford

Amy Rochford

Clinical
Paula Rothwell

Paula Rothwell

Clinical Supply Chain
Mikhaila Ruth

Mikhaila Ruth

Human Resources
Prabjyot Sachdev

Prabjyot Sachdev

Corporate Development
Manoj Samant

Manoj Samant, PhD

Clinical
Danieska Sandino

Danieska Sandino, MBA

Clinical
Christine Schneeberg

Christine Schneeberg

Clinical Supply Chain
Maureen Secord

Maureen Secord

Clinical Supply Chain

Jimmy Shannon

Quality

Ally Shou, PhD, JD

Legal
Sizemore Jacob

Jacob Sizemore, PhD

Pharmaceutical Development
Greg Smith

Greg Smith, MS

Regulatory Affairs
John Soglia

John Soglia, PhD

Senior Vice President, Translational Development
Kevin Staffin

Kevin Staffin

Quality
Yuting Sun

Yuting Sun, PhD

Biology
Wint Swe

Wint Swe, MBBS, MBA

Clinical
Anupong Tangpeerachaikul

Anupong Tangpeerachaikul, PhD

Biology
Christopher Turner

Christopher Turner, MD

Chief Medical Officer
Vivek Upadhyay

Vivek Upadhyay, MD, MBI

Clinical
Virginia Vetter

Virginia Vetter, MS

Regulatory Affairs
Brenda Vienneau

Brenda Vienneau, CPA, CMA

Finance
Walker-Morgan

Morgan Walker, PhD

Pharmaceutical Development
Wash Michael

Michael Walsh, PhD

Biology
Stacia Wegst Uhrich

Stacia Wegst-Uhrich, PhD

Pharmaceutical Development
Carla Whalen

Carla Whalen

Human Resources
Williams-Brett

Brett Williams, PhD

Chemistry
Wilson Lindsey

Lindsey Wilson, MS

Clinical
Jimmy Yung

Jimmy Yung

Finance
Viola Zhu

Viola Zhu, MD, PhD

Clinical
Fareya Zubair

Fareya Zubair, MS

Regulatory Affairs
Emily Darbant Conley

Emily Drabant Conley, PhD

Chief Executive Officer, Renasant Bio
Gary Gilliland

Gary Gilliland, MD, PhD

Independent Board Member
Andrew A.F. Hack

Andrew A. F. Hack, MD, PhD

Managing Director, Bain Capital Life Sciences
Michael Meyers

Michael Meyers, MD, PhD

Chief Medical Officer, Flare Therapeutics
Joseph Pearlberg

Joseph Pearlberg, MD, PhD

VP of Scientific Affairs, Deerfield Management
Anna Protopapas

Anna Protopapas

Independent Board Member
Matthew D. Shair

Matthew D. Shair, PhD

Founder, Head Scientific Advisor
Sapna Srivastava

Sapna Srivastava, PhD

Independent Board Member
Cameron Wheeler

Cameron Wheeler, PhD

Partner, Deerfield Management

Our clinical trials

Learn More
Read the latest news

Nuvalent Highlights Corporate and Pipeline Achievements, Reiterates Key Anticipated Milestones, and Reports Third Quarter 2024 Financial Results

Nuvalent Announces Closing of Upsized Public Offering of Common Stock

Nuvalent Announces Pricing of Upsized Public Offering of Common Stock